𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Trial of Weekly Paclitaxel, Cisplatin Plus Infusional High Dose 5-Fluorouracil and Leucovorin for Metastatic Urothelial Carcinoma

✍ Scribed by Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Vogelzang, Nicholas J.; Pu, Yeong-Shiau

Book ID
123477451
Publisher
Lippincott Williams and Wilkins
Year
2007
Tongue
English
Weight
100 KB
Volume
177
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of methotrexate, cispla
A phase II trial of methotrexate, cisplatin, 5-fluorouracil, and leucovorin in the treatment of invasive and metastatic urothelial carcinoma
✍ William K. Oh; Judith Manola; Jerome P. Richie; Kevin R. Loughlin; Philip W. Kan πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 78 KB πŸ‘ 2 views

The current treatment of advanced urothelial carcinoma generates high response rates but is associated with poor overall survival. The current study evaluated the efficacy and toxicity of a new combination of active drugs in the treatment of urothelial carcinoma. ## METHODS. Twenty-four patients

Outpatient weekly 24-hour infusional adj
Outpatient weekly 24-hour infusional adjuvant chemotherapy of cisplatin, 5-fluorouracil, and leucovorin for high-risk nasopharyngeal carcinoma
✍ Jin-Ching Lin; Jian-Sheng Jan; Kuang Y. Chen; Chen-Yi Hsu; Wen-Miin Liang; Wen-Y πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 165 KB

## Abstract ## Background. Distant metastasis rather than locoregional recurrence is the major site of failure after adequate radiotherapy in nasopharyngeal carcinoma (NPC). The aim of this study is to evaluate the toxicity and survival of outpatient weekly 24‐hour infusion adjuvant chemotherapy f